Expert Forum on Bladder Cancer: Bladder-sparing treatment


“We need better tests and better biomarkers to try to determine who still has residual cancer, even though they look like they don't,” says Christopher B. Anderson, MD, MPH.

In this video, Sam S. Chang, MD, MBA, Chad R. Ritch, MD, MBA, FACS,and Christopher B. Anderson, MD, MPH, discuss the most recent guidelines and research regarding bladder-sparing techniques for patients with muscle-invasive and non–muscle invasive bladder cancer. This discussion is part of a larger forum on bladder cancer.

Chang is a Patricia and Rodes Hart professor of urology and oncology at the Vanderbilt University Medical Center and chief surgical officer at the Vanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. Ritch is an associate professor of urology and an associate director of UHealth International at the Miller School of Medicine, University of Miami, Florida. Anderson is an assistant professor of urology at Columbia University Irving Medical Center, Columbia University, New York City, New York.

Related Videos
Nicholas L. Kavoussi, MD, answers a question during a Zoom video interview
Doctor typing on computer | Image Credit: © smolaw11 -
Christopher J.D. Wallis, MD, PhD, answers a question during a Zoom video interview
3d rendered illustration of bladder cancer | Image Credit: © SciePro -
Blur image of hospital corridor | Image Credit: © whyframeshot -
Conference of doctors | Image Credit:  ©  Aydan -
Udit Singhal, MD, answers a question during a zoom video interview
Randall A. Lee, MD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.